AHRQ National Research Service Award (NRSA) Institutional Research Training Grant (T32) (Letter of Intent Due Date(s) – Oct 14)
Notice of Participation of the National Institute on Aging (NIA) in RFA-DA-23-051, “HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 – Clinical Trials Optional)”
New Funding Opportunity for Research on Fostering Behavioral Health Among Children in School (Due by Oct 28)
HHS announces award of $2 million grant to the American Academy of Pediatrics to establish National Center of Excellence on Social Media and Mental Wellness
Notice of Special Interest (NOSI): Research on the Health of Bisexual and Bisexual+ People (First available due date: Sept 25)
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed) (Letter of intent due date: 30 days prior to the application due date)
Notice of Intent to Publish a Funding Opportunity Announcement for Community Partnerships to Advance Science for Society (ComPASS): Coordination Center (U24 – Clinical Trial Optional)
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional) (Letter of intent 30 days prior to each application due date, first application due date: Nov 14)
Notice of Special Interest (NOSI) HEAL Initiative: Workforce Interventions to Improve Addiction Care Quality and Patient Outcomes (First available due date: Oct 5)
Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) (First application due date: Dec 7)
Upcoming Research Opportunity Announcement (ROA) for Community Partnerships to Advance Science for Society (ComPASS) Program: Community-Led, Health Equity Structural Intervention Initiative (CHESI) (OT2 Clinical Trial Optional)
Notice of Special Interest (NOSI): HEAL Initiative: Opioid Use Disorder Care Pathways for Individuals with Histories of Exposure to Violence (First available due date: Oct 12)
HEAL Initiative: Research Studies to Develop and Implement Interventions to Prevent Opioid Misuse in Community Health Centers (R61/R33 Clinical Trial Required) (Letter of intent due date: Oct 8)
Notice of Intent to Publish a Funding Opportunity Announcement for Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional) (First Available Due Date: Oct 1)
HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional) (Letter of intent due 30 days prior to application, first application due date: Nov 14)
Alzheimer’s-related Resource Centers for Minority Aging Research (AD/ADRD RCMAR) (P30 Clinical Trial Optional) (Letter of Intent Due Date(s): Sept 21)
Expanding Collaborative Implementation Science to Address Social and Structural Determinants of Health and Improve HIV Outcomes (R01 Clinical Trial Required)
Lessening the Burden of Student Loans: Apply for NIH Student Loan Repayment September 1–November 17, 2022
HEAL Initiative: Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On (RM1 – Clinical Trial Optional) (Letter of intent due by Jan 2)
Notice of Intent to Publish a Funding Opportunity Announcement for NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Clinical Trial Not Allowed)